Healthcare -
Biotechnology - NASDAQ - US
$ 0.6594
0.687 %
$ 2.44 M
Market Cap
-0.14
P/E
PCSA - COST OF REVENUE
Cost of Revenue PCSA - Processa Pharmaceuticals, Inc.
222
LAST VALUE
-99.57%
2 YEAR CAGR
-79.61%
5 YEAR CAGR
-49.04%
10 YEAR CAGR